<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="7303813 doi: 10.3389/fped.2020.00285 : Pediatrics: Original Research Long-Term Outcomes of" exact="Pediatric" post="Enterovirus Infection in Taiwan: A Population-Based Cohort Study TsengJui-Ju12LinChien-Heng3LinMing-Chih145*[],"/>
 <result pre="10.3389/fped.2020.00285 : Pediatrics: Original Research Long-Term Outcomes of Pediatric Enterovirus" exact="Infection" post="in Taiwan: A Population-Based Cohort Study TsengJui-Ju12LinChien-Heng3LinMing-Chih145*[], 1Children's Medical"/>
 <result pre="A Population-Based Cohort Study TsengJui-Ju12LinChien-Heng3LinMing-Chih145*[], 1Children's Medical Center, Taichung Veterans" exact="General" post="HospitalTaichungTaiwan[], 2Institute of Clinical Medicine, National Yang-Ming UniversityTaipeiTaiwan[], 3Department"/>
 <result pre="Medicine, National Yang-Ming UniversityTaipeiTaiwan[], 3Department of Medical Research, Taichung Veterans" exact="General" post="HospitalTaichungTaiwan[], 4School of Medicine, National Yang-Ming UniversityTaipeiTaiwan[], 5Department of"/>
 <result pre="these terms. Abstract Introduction: The major burden of diseases in" exact="childhood" post="has shifted from infectious diseases to chronic health conditions"/>
 <result pre="The major burden of diseases in childhood has shifted from" exact="infectious diseases" post="to chronic health conditions in recent decades. Although the"/>
 <result pre="of diseases in childhood has shifted from infectious diseases to" exact="chronic" post="health conditions in recent decades. Although the rates of"/>
 <result pre="chronic health conditions in recent decades. Although the rates of" exact="infectious diseases" post="have decreased, the incidence of chronic diseases stemming from"/>
 <result pre="the rates of infectious diseases have decreased, the incidence of" exact="chronic" post="diseases stemming from infectious agents continues to grow. Enterovirus"/>
 <result pre="diseases have decreased, the incidence of chronic diseases stemming from" exact="infectious" post="agents continues to grow. Enterovirus is a major infectious"/>
 <result pre="from infectious agents continues to grow. Enterovirus is a major" exact="infectious disease" post="of childhood and has been linked to numerous chronic"/>
 <result pre="infectious agents continues to grow. Enterovirus is a major infectious" exact="disease" post="of childhood and has been linked to numerous chronic"/>
 <result pre="continues to grow. Enterovirus is a major infectious disease of" exact="childhood" post="and has been linked to numerous chronic diseases. We"/>
 <result pre="infectious disease of childhood and has been linked to numerous" exact="chronic" post="diseases. We analyzed population-based data from Taiwan's National Health"/>
 <result pre="Insurance Research Database (NHIRD) to investigate the correlations between enterovirus" exact="infection" post="and major chronic health conditions in children. Method: Children"/>
 <result pre="(NHIRD) to investigate the correlations between enterovirus infection and major" exact="chronic" post="health conditions in children. Method: Children diagnosed with enterovirus"/>
 <result pre="health conditions in children. Method: Children diagnosed with enterovirus (EV)" exact="infection" post="during 1999–2003 were identified from the Longitudinal Health Insurance"/>
 <result pre="subdataset of Taiwan's National Health Insurance Research Database (NHIRD). A" exact="total" post="of 14,168 patients were selected after excluding patients with"/>
 <result pre="of 14,168 patients were selected after excluding patients with existing" exact="chronic" post="diseases and missing data. Another 14,168 children matched by"/>
 <result pre="age and sex were selected as the control group. Five" exact="primary" post="outcomes, including attention deficit and hyperactivity disorder (ADHD), epilepsy,"/>
 <result pre="outcomes, including attention deficit and hyperactivity disorder (ADHD), epilepsy, asthma," exact="allergic rhinitis," post="and atopic dermatitis, were recorded. Results: The risks of"/>
 <result pre="deficit and hyperactivity disorder (ADHD), epilepsy, asthma, allergic rhinitis, and" exact="atopic dermatitis," post="were recorded. Results: The risks of ADHD, asthma, allergic"/>
 <result pre="atopic dermatitis, were recorded. Results: The risks of ADHD, asthma," exact="allergic rhinitis," post="and epilepsy were significantly increased in the EV group"/>
 <result pre="recorded. Results: The risks of ADHD, asthma, allergic rhinitis, and" exact="epilepsy" post="were significantly increased in the EV group compared with"/>
 <result pre="EV group compared with the control group. The risk of" exact="atopic dermatitis" post="was significantly increased in the crude model. However, there"/>
 <result pre="group compared with the control group. The risk of atopic" exact="dermatitis" post="was significantly increased in the crude model. However, there"/>
 <result pre="differences in the adjusted model. The risks of ADHD, asthma," exact="allergic rhinitis," post="and epilepsy were also significantly increased in patients with"/>
 <result pre="adjusted model. The risks of ADHD, asthma, allergic rhinitis, and" exact="epilepsy" post="were also significantly increased in patients with severe EV"/>
 <result pre="epilepsy were also significantly increased in patients with severe EV" exact="infection" post="compared with patients with non-severe EV infection. Conclusion: Chronic"/>
 <result pre="EV infection compared with patients with non-severe EV infection. Conclusion:" exact="Chronic" post="diseases, such as ADHD, epilepsy, asthma, allergic rhinitis, and"/>
 <result pre="EV infection. Conclusion: Chronic diseases, such as ADHD, epilepsy, asthma," exact="allergic rhinitis," post="and atopic dermatitis were shown to be associated with"/>
 <result pre="Chronic diseases, such as ADHD, epilepsy, asthma, allergic rhinitis, and" exact="atopic dermatitis" post="were shown to be associated with enterovirus infection during"/>
 <result pre="diseases, such as ADHD, epilepsy, asthma, allergic rhinitis, and atopic" exact="dermatitis" post="were shown to be associated with enterovirus infection during"/>
 <result pre="and atopic dermatitis were shown to be associated with enterovirus" exact="infection" post="during childhood. EV infection during early childhood might have"/>
 <result pre="shown to be associated with enterovirus infection during childhood. EV" exact="infection" post="during early childhood might have long-term public health implications"/>
 <result pre="associated with enterovirus infection during childhood. EV infection during early" exact="childhood" post="might have long-term public health implications and thus prevention"/>
 <result pre="implications and thus prevention strategies should be implemented. enterovirus ADHD" exact="epilepsy" post="allergic disease NHIRD fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
 <result pre="and thus prevention strategies should be implemented. enterovirus ADHD epilepsy" exact="allergic disease" post="NHIRD fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The"/>
 <result pre="thus prevention strategies should be implemented. enterovirus ADHD epilepsy allergic" exact="disease" post="NHIRD fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The"/>
 <result pre="table-count: equation-count: ref-count: page-count: word-count: Introduction The major burden of" exact="disease" post="in children and adolescents has shifted from infectious diseases"/>
 <result pre="burden of disease in children and adolescents has shifted from" exact="infectious diseases" post="to chronic health conditions in recent decades (1, 2)."/>
 <result pre="in children and adolescents has shifted from infectious diseases to" exact="chronic" post="health conditions in recent decades (1, 2). Although rates"/>
 <result pre="health conditions in recent decades (1, 2). Although rates of" exact="infectious diseases" post="have decreased, it appears that chronic diseases stemming from"/>
 <result pre="Although rates of infectious diseases have decreased, it appears that" exact="chronic" post="diseases stemming from infectious agents are on the rise."/>
 <result pre="diseases have decreased, it appears that chronic diseases stemming from" exact="infectious" post="agents are on the rise. Infections may simply be"/>
 <result pre="chronic diseases stemming from infectious agents are on the rise." exact="Infections" post="may simply be the first misstep along a continuum"/>
 <result pre="disability and diseases (3). Enteroviruses are among the most common" exact="infectious" post="pathogens in infants and children. They are associated various"/>
 <result pre="conjunctivitis, and various exanthems), CNS involvement (aseptic meningitis, encephalitis, poliomyelitis," exact="Guillain-Barré syndrome," post="etc.), heart infection (myopericarditis), neonatal infection, and newly recognized"/>
 <result pre="exanthems), CNS involvement (aseptic meningitis, encephalitis, poliomyelitis, Guillain-Barré syndrome, etc.)," exact="heart" post="infection (myopericarditis), neonatal infection, and newly recognized clinical syndrome"/>
 <result pre="CNS involvement (aseptic meningitis, encephalitis, poliomyelitis, Guillain-Barré syndrome, etc.), heart" exact="infection" post="(myopericarditis), neonatal infection, and newly recognized clinical syndrome (asthma"/>
 <result pre="(aseptic meningitis, encephalitis, poliomyelitis, Guillain-Barré syndrome, etc.), heart infection (myopericarditis)," exact="neonatal infection," post="and newly recognized clinical syndrome (asthma exacerbation secondary to"/>
 <result pre="etc.), heart infection (myopericarditis), neonatal infection, and newly recognized clinical" exact="syndrome" post="(asthma exacerbation secondary to EV D68 and Eczema Coxsackium)"/>
 <result pre="(myopericarditis), neonatal infection, and newly recognized clinical syndrome (asthma exacerbation" exact="secondary" post="to EV D68 and Eczema Coxsackium) (4, 5). Enterovirus"/>
 <result pre="(EV71) is responsible for a number of large epidemics of" exact="hand, foot, and mouth disease" post="in children, and in rare cases can lead to"/>
 <result pre="a number of large epidemics of hand, foot, and mouth" exact="disease" post="in children, and in rare cases can lead to"/>
 <result pre="cases can lead to a serious complication known as EV71" exact="neurological disease" post="(6). The largest and most severe outbreak of EV71"/>
 <result pre="can lead to a serious complication known as EV71 neurological" exact="disease" post="(6). The largest and most severe outbreak of EV71"/>
 <result pre="in Taiwan occurred in 1998 (7). Mortalities due to enterovirus" exact="infection" post="decreased following the introduction of national stage-based management guidelines"/>
 <result pre="in the management of this disease. Besides neurological sequelae, enterovirus" exact="infection" post="has been shown to have other long-term effects resulting"/>
 <result pre="other long-term effects resulting in common health problems, such as" exact="allergy" post="diseases, autoimmune diseases, and diseases involving other systems, and"/>
 <result pre="effects resulting in common health problems, such as allergy diseases," exact="autoimmune" post="diseases, and diseases involving other systems, and for this"/>
 <result pre="and diseases involving other systems, and for this reason enterovirus" exact="infection" post="has become a major public health issue in children"/>
 <result pre="children (5, 9). This study investigated the relationship between enterovirus" exact="infection" post="and common health problems in children from a population-based"/>
 <result pre="is shown in Figure 1. Since the cases of EV" exact="infection" post="surged due to the endemic outbreak in 1998 in"/>
 <result pre="in Taiwan, we chose to study since 1999 for clearer" exact="disease" post="status definition. This is a claim data study. The"/>
 <result pre="by NHI of Taiwan during the study period. Symptomatic enterovirus" exact="infection" post="(herpangina, hand-foot-mouth disease, enterovirus infection with CNS diseases) was"/>
 <result pre="the study period. Symptomatic enterovirus infection (herpangina, hand-foot-mouth disease, enterovirus" exact="infection" post="with CNS diseases) was defined as patients coded as"/>
 <result pre="074. For the period 1999–2003, 49,236 patients with enterovirus (EV)" exact="infection" post="(ICD-9-CM 047-049, 074) were identified from the LHID2000. Children"/>
 <result pre="with attention deficit and hyperactive disorder (ADHD), epilepsy, atopic diseases," exact="coronary artery disease" post="(CAD), stroke, rheumatoid arthritis (RA), or systemic lupus erythematosus"/>
 <result pre="attention deficit and hyperactive disorder (ADHD), epilepsy, atopic diseases, coronary" exact="artery disease" post="(CAD), stroke, rheumatoid arthritis (RA), or systemic lupus erythematosus"/>
 <result pre="deficit and hyperactive disorder (ADHD), epilepsy, atopic diseases, coronary artery" exact="disease" post="(CAD), stroke, rheumatoid arthritis (RA), or systemic lupus erythematosus"/>
 <result pre="disorder (ADHD), epilepsy, atopic diseases, coronary artery disease (CAD), stroke," exact="rheumatoid arthritis" post="(RA), or systemic lupus erythematosus (SLE) before the diagnosis"/>
 <result pre="(ADHD), epilepsy, atopic diseases, coronary artery disease (CAD), stroke, rheumatoid" exact="arthritis" post="(RA), or systemic lupus erythematosus (SLE) before the diagnosis"/>
 <result pre="diseases, coronary artery disease (CAD), stroke, rheumatoid arthritis (RA), or" exact="systemic" post="lupus erythematosus (SLE) before the diagnosis of enterovirus were"/>
 <result pre="coronary artery disease (CAD), stroke, rheumatoid arthritis (RA), or systemic" exact="lupus erythematosus" post="(SLE) before the diagnosis of enterovirus were excluded. Subjects"/>
 <result pre="to parental occupation and urbanization were also excluded. Finally, a" exact="total" post="of 14,168 subjects were included in the study. EV"/>
 <result pre="total of 14,168 subjects were included in the study. EV" exact="infection" post="was further categorized according to level of severity based"/>
 <result pre="of EV infection. Subjects who were not hospitalized for EV" exact="infection" post="were categorized as having a non-severe EV infection. Subjects"/>
 <result pre="a non-severe EV infection. Subjects who were hospitalized for EV" exact="infection" post="were categorized as having a severe EV infection. The"/>
 <result pre="control group comprised individuals who were not diagnosed with EV" exact="infection" post="during 1999–2003 matched by age and sex at a"/>
 <result pre="NHI program, a major outcome such as ADHD, epilepsy, asthma," exact="allergic rhinitis," post="or atopic dermatitis occurred, or until December 31, 2013"/>
 <result pre="major outcome such as ADHD, epilepsy, asthma, allergic rhinitis, or" exact="atopic dermatitis" post="occurred, or until December 31, 2013 was reached, as"/>
 <result pre="outcome such as ADHD, epilepsy, asthma, allergic rhinitis, or atopic" exact="dermatitis" post="occurred, or until December 31, 2013 was reached, as"/>
 <result pre="from EV. Major outcomes were as follows: ADHD (ICD-9-CM 314)," exact="epilepsy" post="(ICD-9-CM 345), asthma (ICD-9-CM 493), allergic rhinitis (ICD-9-CM 477),"/>
 <result pre="outcomes were as follows: ADHD (ICD-9-CM 314), epilepsy (ICD-9-CM 345)," exact="asthma" post="(ICD-9-CM 493), allergic rhinitis (ICD-9-CM 477), and atopic dermatitis"/>
 <result pre="follows: ADHD (ICD-9-CM 314), epilepsy (ICD-9-CM 345), asthma (ICD-9-CM 493)," exact="allergic rhinitis" post="(ICD-9-CM 477), and atopic dermatitis (ICD-9-CM 691). Demographic variables"/>
 <result pre="ADHD (ICD-9-CM 314), epilepsy (ICD-9-CM 345), asthma (ICD-9-CM 493), allergic" exact="rhinitis" post="(ICD-9-CM 477), and atopic dermatitis (ICD-9-CM 691). Demographic variables"/>
 <result pre="(ICD-9-CM 345), asthma (ICD-9-CM 493), allergic rhinitis (ICD-9-CM 477), and" exact="atopic dermatitis" post="(ICD-9-CM 691). Demographic variables including age, sex, parental occupation,"/>
 <result pre="345), asthma (ICD-9-CM 493), allergic rhinitis (ICD-9-CM 477), and atopic" exact="dermatitis" post="(ICD-9-CM 691). Demographic variables including age, sex, parental occupation,"/>
 <result pre="was approved by the Institutional Review Board of Taichung Veterans" exact="General" post="Hospital (IRB TCVGH No. CE17178A-2). Statistical Analysis SAS 9.4"/>
 <result pre="was used for comparing categorical variables. The incidence of each" exact="disease" post="was calculated using the incidence density. For assessing the"/>
 <result pre="The study population consisted of 14,168 children diagnosed with EV" exact="infection" post="and 14,168 children without EV infection. Table 1 shows"/>
 <result pre="(81.5) 11,551 (81.5) ≥6 2,617 (18.5) 2,617 (18.5) Sex 0.99" exact="Female" post="7,008 (49.5) 7,008 (49.5) Male 7,160 (50.5) 7,160 (50.5)"/>
 <result pre="control group (HR = 1.25, 95%CI-1.11–1.41). The incidence rates of" exact="epilepsy" post="were 13.7/10,000 person-years and 10.7/10,000 person-years in the EV"/>
 <result pre="confounding factors, there was a 1.25 times higher risk for" exact="epilepsy" post="in the EV cohort group compared with the control"/>
 <result pre="Three major allergic diseases were analyzed in this study: asthma," exact="allergic rhinitis," post="and atopic dermatitis. The incidence of asthma was 150/10,000"/>
 <result pre="diseases were analyzed in this study: asthma, allergic rhinitis, and" exact="atopic dermatitis." post="The incidence of asthma was 150/10,000 person-years in the"/>
 <result pre="study: asthma, allergic rhinitis, and atopic dermatitis. The incidence of" exact="asthma" post="was 150/10,000 person-years in the EV cohort group and"/>
 <result pre="and 93.0/10,000 person-years in the control group. The risk of" exact="asthma" post="was higher in the EV cohort group after adjusting"/>
 <result pre="confounders (HR = 1.49, 95%CI = 1.41–1.58). The incidence of" exact="allergic rhinitis" post="in the EV cohort group was 1.37 times higher"/>
 <result pre="(HR = 1.49, 95%CI = 1.41–1.58). The incidence of allergic" exact="rhinitis" post="in the EV cohort group was 1.37 times higher"/>
 <result pre="confounding factors, there was a 1.37 times higher risk for" exact="allergic rhinitis" post="in the EV cohort group (HR = 1.37, 95%CI"/>
 <result pre="factors, there was a 1.37 times higher risk for allergic" exact="rhinitis" post="in the EV cohort group (HR = 1.37, 95%CI"/>
 <result pre="(HR = 1.37, 95%CI = 1.33–1.42). The incidence rates of" exact="atopic dermatitis" post="were 45.6 and 39.3/10,000 person-years, respectively. However, after adjusting"/>
 <result pre="= 1.37, 95%CI = 1.33–1.42). The incidence rates of atopic" exact="dermatitis" post="were 45.6 and 39.3/10,000 person-years, respectively. However, after adjusting"/>
 <result pre="confounders, there was no significant difference in the risk of" exact="atopic dermatitis" post="between the two groups (HR = 1.09, 95%CI ="/>
 <result pre="there was no significant difference in the risk of atopic" exact="dermatitis" post="between the two groups (HR = 1.09, 95%CI ="/>
 <result pre="497 177,328 28.0 658 308,504 21.3 1.30 (1.16–1.46) 1.25 (1.11–1.41)" exact="Epilepsy" post="245 178,880 13.7 331 310,557 10.7 1.27 (1.08–1.50) 1.25"/>
 <result pre="245 178,880 13.7 331 310,557 10.7 1.27 (1.08–1.50) 1.25 (1.06–1.47)" exact="Asthma" post="2,343 156,650 150 2,663 286,305 93.0 1.56 (1.48–1.65) 1.49"/>
 <result pre="2,343 156,650 150 2,663 286,305 93.0 1.56 (1.48–1.65) 1.49 (1.41–1.58)" exact="Allergic" post="rhinitis 5,812 125,691 462 7,677 243,124 316 1.42 (1.37–1.47)"/>
 <result pre="156,650 150 2,663 286,305 93.0 1.56 (1.48–1.65) 1.49 (1.41–1.58) Allergic" exact="rhinitis" post="5,812 125,691 462 7,677 243,124 316 1.42 (1.37–1.47) 1.37"/>
 <result pre="5,812 125,691 462 7,677 243,124 316 1.42 (1.37–1.47) 1.37 (1.33–1.42)" exact="Atopic dermatitis" post="791 173,414 45.6 1,188 302,104 39.3 1.14 (1.05–1.25) 1.09"/>
 <result pre="125,691 462 7,677 243,124 316 1.42 (1.37–1.47) 1.37 (1.33–1.42) Atopic" exact="dermatitis" post="791 173,414 45.6 1,188 302,104 39.3 1.14 (1.05–1.25) 1.09"/>
 <result pre="for children with or without EV infection. (A) asthma, (B)" exact="allergic rhinitis," post="(C) atopic dermatitis. Figure 3 Cumulative risk of CNS"/>
 <result pre="or without EV infection. (A) asthma, (B) allergic rhinitis, (C)" exact="atopic dermatitis." post="Figure 3 Cumulative risk of CNS sequelae for children"/>
 <result pre="five major events between patients with severe or non-severe EV" exact="infection" post="was demonstrated in Table 3. With regard to neurologic"/>
 <result pre="(HR = 1.12, 95% CI = 0.84–1.47). The incidence of" exact="epilepsy" post="was 29.5/10,000 person-years in patients with severe EV infection"/>
 <result pre="of epilepsy was 29.5/10,000 person-years in patients with severe EV" exact="infection" post="and 12.1/10,000 person-years in patients with non-severe EV infection."/>
 <result pre="severe EV patients had a 2.36 times greater risk for" exact="epilepsy" post="(HR = 2.36, 95%CI = 1.62–3.24). Comparing the risk"/>
 <result pre="the two groups, there was no difference in risk of" exact="atopic dermatitis" post="(HR = 1.10, 95%CI = 0.88–1.38), but there was"/>
 <result pre="two groups, there was no difference in risk of atopic" exact="dermatitis" post="(HR = 1.10, 95%CI = 0.88–1.38), but there was"/>
 <result pre="95%CI = 0.88–1.38), but there was a higher risk of" exact="asthma" post="(HR = 1.33, 95%CI = 1.18–1.50) and allergic rhinitis"/>
 <result pre="risk of asthma (HR = 1.33, 95%CI = 1.18–1.50) and" exact="allergic rhinitis" post="(HR = 1.17, 95%CI = 1.08–1.28) in patients with"/>
 <result pre="of asthma (HR = 1.33, 95%CI = 1.18–1.50) and allergic" exact="rhinitis" post="(HR = 1.17, 95%CI = 1.08–1.28) in patients with"/>
 <result pre="major events were compared between the severe EV and non-severe" exact="infection" post="groups (Figures 4, 5). Table 3 The risk of"/>
 <result pre="events for children with or without severe EV infection*. Outcomes" exact="Severe" post="EV71 Non-severe EV71 Crude HR Adjusted HR* (95% CI)"/>
 <result pre="57 16,680 34.2 440 160,647 27.4 1.27 (0.96–1.67) 1.12 (0.84–1.47)" exact="Epilepsy" post="49 16,587 29.5 196 162,293 12.1 2.45 (1.79–3.35) 2.36"/>
 <result pre="49 16,587 29.5 196 162,293 12.1 2.45 (1.79–3.35) 2.36 (1.72–3.24)" exact="Asthma" post="306 13,762 222 2,037 142,888 143 1.55 (1.37–1.75) 1.33"/>
 <result pre="306 13,762 222 2,037 142,888 143 1.55 (1.37–1.75) 1.33 (1.18–1.50)" exact="Allergic" post="rhinitis 617 10,915 565 5,195 114,776 453 1.24 (1.14–1.35)"/>
 <result pre="13,762 222 2,037 142,888 143 1.55 (1.37–1.75) 1.33 (1.18–1.50) Allergic" exact="rhinitis" post="617 10,915 565 5,195 114,776 453 1.24 (1.14–1.35) 1.17"/>
 <result pre="617 10,915 565 5,195 114,776 453 1.24 (1.14–1.35) 1.17 (1.08–1.28)" exact="Atopic dermatitis" post="87 16,190 53.7 704 157,224 44.8 1.21 (0.97–1.52) 1.10"/>
 <result pre="10,915 565 5,195 114,776 453 1.24 (1.14–1.35) 1.17 (1.08–1.28) Atopic" exact="dermatitis" post="87 16,190 53.7 704 157,224 44.8 1.21 (0.97–1.52) 1.10"/>
 <result pre="children with severe and non-severe EV infection. (A) asthma, (B)" exact="allergic rhinitis," post="(C) atopic dermatitis. Figure 5 Cumulative risk of CNS"/>
 <result pre="and non-severe EV infection. (A) asthma, (B) allergic rhinitis, (C)" exact="atopic dermatitis." post="Figure 5 Cumulative risk of CNS sequelae for children"/>
 <result pre="over recent decades (1, 2, 10). The impacts of serious" exact="childhood" post="infectious diseases have declined gradually; however, the incidence of"/>
 <result pre="recent decades (1, 2, 10). The impacts of serious childhood" exact="infectious diseases" post="have declined gradually; however, the incidence of chronic health"/>
 <result pre="childhood infectious diseases have declined gradually; however, the incidence of" exact="chronic" post="health conditions has risen steadily. The reasons for these"/>
 <result pre="to be due to improved nutrition and sanitation, implementation of" exact="childhood" post="immunization programs for preventing severe pathogens, medical advances in"/>
 <result pre="programs for preventing severe pathogens, medical advances in both treating" exact="primary" post="diseases and managing serious complications, and better public awareness"/>
 <result pre="diseases and managing serious complications, and better public awareness of" exact="chronic" post="health conditions (1). Much of the rise in chronic"/>
 <result pre="of chronic health conditions (1). Much of the rise in" exact="chronic" post="health conditions can be attributed to four common diseases,"/>
 <result pre="and neurodevelopmental disorders. There is a growing recognition that certain" exact="chronic" post="diseases stem from infectious diseases. Recent advances in diagnostic"/>
 <result pre="is a growing recognition that certain chronic diseases stem from" exact="infectious diseases." post="Recent advances in diagnostic techniques have enabled researchers to"/>
 <result pre="have enabled researchers to prove a causal relationship between various" exact="infectious" post="agents and chronic diseases (3). According to long-term data"/>
 <result pre="to prove a causal relationship between various infectious agents and" exact="chronic" post="diseases (3). According to long-term data gathered by Taiwan's"/>
 <result pre="number of outpatients and emergency visits due to enterovirus, i.e.," exact="herpangina" post="or hand-foot-mouth disease, increases during late March, peaks around"/>
 <result pre="Children under 5 years old are more prone to enterovirus" exact="infection" post="with severe complications, resulting in case-fatality rates ranging from"/>
 <result pre="also reported more than 93% of cases with severe enterovirus" exact="infection" post="were found in children who were younger than 4"/>
 <result pre="a number of severe diseases and complications (6). Besides hand-foot-mouth" exact="disease" post="(HFMD) and herpangina, this virus can be potentially complicated"/>
 <result pre="function, remain a major concern in the management of this" exact="disease" post="(8, 16). In addition to neurological sequelae, enterovirus infection"/>
 <result pre="this disease (8, 16). In addition to neurological sequelae, enterovirus" exact="infection" post="is thought to have a long-term impact on various"/>
 <result pre="allergic diseases, and diseases involving other systems, and thus enterovirus" exact="infection" post="is becoming a major public health issue in children"/>
 <result pre="There was a higher risk of ADHD, epilepsy, asthma, and" exact="allergic rhinitis" post="in children with severe EV infection compared with children"/>
 <result pre="was a higher risk of ADHD, epilepsy, asthma, and allergic" exact="rhinitis" post="in children with severe EV infection compared with children"/>
 <result pre="epilepsy, asthma, and allergic rhinitis in children with severe EV" exact="infection" post="compared with children with non-severe EV infection. The cumulative"/>
 <result pre="non-severe EV infection. The cumulative risks for ADHD, epilepsy, asthma," exact="allergic rhinitis," post="and atopic dermatitis were significantly increased in children with"/>
 <result pre="The cumulative risks for ADHD, epilepsy, asthma, allergic rhinitis, and" exact="atopic dermatitis" post="were significantly increased in children with EV infection, especially"/>
 <result pre="cumulative risks for ADHD, epilepsy, asthma, allergic rhinitis, and atopic" exact="dermatitis" post="were significantly increased in children with EV infection, especially"/>
 <result pre="children with EV infection, especially in children with severe EV" exact="infection" post="in the follow-up period. Viral CNS infections during childhood"/>
 <result pre="in children with severe EV infection in the follow-up period." exact="Viral" post="CNS infections during childhood have been documented to be"/>
 <result pre="with severe EV infection in the follow-up period. Viral CNS" exact="infections" post="during childhood have been documented to be associated with"/>
 <result pre="EV infection in the follow-up period. Viral CNS infections during" exact="childhood" post="have been documented to be associated with later development"/>
 <result pre="later development of long-term neurologic sequelae, such as limb weakness," exact="cranial nerve palsy," post="cerebral palsy, non-affective psychotic illness, cognitive impairment, attention deficit"/>
 <result pre="development of long-term neurologic sequelae, such as limb weakness, cranial" exact="nerve" post="palsy, cerebral palsy, non-affective psychotic illness, cognitive impairment, attention"/>
 <result pre="long-term neurologic sequelae, such as limb weakness, cranial nerve palsy," exact="cerebral palsy," post="non-affective psychotic illness, cognitive impairment, attention deficit hyperactivity disorder"/>
 <result pre="limb weakness, cranial nerve palsy, cerebral palsy, non-affective psychotic illness," exact="cognitive impairment," post="attention deficit hyperactivity disorder (ADHD), learning disability, and epilepsy"/>
 <result pre="cranial nerve palsy, cerebral palsy, non-affective psychotic illness, cognitive impairment," exact="attention deficit hyperactivity disorder" post="(ADHD), learning disability, and epilepsy (16–20). Enterovirus has been"/>
 <result pre="non-affective psychotic illness, cognitive impairment, attention deficit hyperactivity disorder (ADHD)," exact="learning disability," post="and epilepsy (16–20). Enterovirus has been reported as one"/>
 <result pre="cognitive impairment, attention deficit hyperactivity disorder (ADHD), learning disability, and" exact="epilepsy" post="(16–20). Enterovirus has been reported as one of the"/>
 <result pre="has been reported as one of the major causes of" exact="viral" post="CNS infection (21, 22). Several studies have assessed the"/>
 <result pre="reported as one of the major causes of viral CNS" exact="infection" post="(21, 22). Several studies have assessed the long-term neurological"/>
 <result pre="(21, 22). Several studies have assessed the long-term neurological sequelae" exact="secondary" post="to enterovirus CNS involvements (16, 23–25). Even when CNS"/>
 <result pre="school (23). In our study, the risks of ADHD and" exact="epilepsy" post="were increased, especially in children with severe EV infection."/>
 <result pre="with enterovirus at a young age. Patients with severe EV" exact="infection" post="are of particular concern in this regard. In the"/>
 <result pre="concern in this regard. In the present study, severe EV" exact="infection" post="identified by hospital admission for EV infection is a"/>
 <result pre="study, severe EV infection identified by hospital admission for EV" exact="infection" post="is a major public health issue that needs to"/>
 <result pre="major public health issue that needs to be urgently addressed." exact="Allergic" post="diseases are increasing in incidence in the general population"/>
 <result pre="school absence and results in significant medical expenditure worldwide (28–31)." exact="Multiple" post="environmental factors also increase the risk of allergic diseases,"/>
 <result pre="(obesity and resident lung microbiome). The innate immune response to" exact="viral" post="infections was reported to be an important factor for"/>
 <result pre="and resident lung microbiome). The innate immune response to viral" exact="infections" post="was reported to be an important factor for inducing"/>
 <result pre="infections was reported to be an important factor for inducing" exact="allergic disease" post="during childhood. Rhinovirus and respiratory syncytial virus-induced respiratory infection"/>
 <result pre="was reported to be an important factor for inducing allergic" exact="disease" post="during childhood. Rhinovirus and respiratory syncytial virus-induced respiratory infection"/>
 <result pre="important factor for inducing allergic disease during childhood. Rhinovirus and" exact="respiratory" post="syncytial virus-induced respiratory infection were shown to be significantly"/>
 <result pre="inducing allergic disease during childhood. Rhinovirus and respiratory syncytial virus-induced" exact="respiratory" post="infection were shown to be significantly correlated with an"/>
 <result pre="allergic disease during childhood. Rhinovirus and respiratory syncytial virus-induced respiratory" exact="infection" post="were shown to be significantly correlated with an increased"/>
 <result pre="shown to be significantly correlated with an increased occurrence of" exact="asthma" post="(35–38). Human enterovirus has been reported to be correlated"/>
 <result pre="enterovirus has been reported to be correlated with development of" exact="allergic disease" post="(39–41). Enterovirus D68 (EV-D68) was identified in 1962, but"/>
 <result pre="has been reported to be correlated with development of allergic" exact="disease" post="(39–41). Enterovirus D68 (EV-D68) was identified in 1962, but"/>
 <result pre="in the United States in 2014. EV-D68 can cause severe" exact="respiratory" post="disease similar to human rhinovirus, and exacerbates the severity"/>
 <result pre="the United States in 2014. EV-D68 can cause severe respiratory" exact="disease" post="similar to human rhinovirus, and exacerbates the severity of"/>
 <result pre="rhinovirus, and exacerbates the severity of symptoms in children with" exact="asthma" post="and wheezing (5, 42). Furthermore, previous studies reported an"/>
 <result pre="Lee et al. observed an increased risk of subsequently developing" exact="allergic dermatitis" post="and allergic rhinitis in children who had previously been"/>
 <result pre="et al. observed an increased risk of subsequently developing allergic" exact="dermatitis" post="and allergic rhinitis in children who had previously been"/>
 <result pre="observed an increased risk of subsequently developing allergic dermatitis and" exact="allergic rhinitis" post="in children who had previously been infected with herpangina"/>
 <result pre="an increased risk of subsequently developing allergic dermatitis and allergic" exact="rhinitis" post="in children who had previously been infected with herpangina"/>
 <result pre="allergic rhinitis in children who had previously been infected with" exact="herpangina" post="and a decreased risk of subsequent occurrence of asthma"/>
 <result pre="with herpangina and a decreased risk of subsequent occurrence of" exact="asthma" post="in children with a prior diagnosis of HFMD compared"/>
 <result pre="population-based database (40). However, in our study, increased risks of" exact="asthma" post="and allergic rhinitis were noted in children who had"/>
 <result pre="(40). However, in our study, increased risks of asthma and" exact="allergic rhinitis" post="were noted in children who had previously had an"/>
 <result pre="However, in our study, increased risks of asthma and allergic" exact="rhinitis" post="were noted in children who had previously had an"/>
 <result pre="were noted in children who had previously had an enterovirus" exact="infection" post="compared to the general population. We also found an"/>
 <result pre="the general population. We also found an increased risk of" exact="asthma" post="and allergic rhinitis in children who had been hospitalized"/>
 <result pre="population. We also found an increased risk of asthma and" exact="allergic rhinitis" post="in children who had been hospitalized with severe enterovirus"/>
 <result pre="We also found an increased risk of asthma and allergic" exact="rhinitis" post="in children who had been hospitalized with severe enterovirus"/>
 <result pre="rhinitis in children who had been hospitalized with severe enterovirus" exact="infection" post="compared to children with non-severe enterovirus infection. Nonetheless, there"/>
 <result pre="there was only a borderline significant difference in risk of" exact="atopic dermatitis" post="between the EV cohort and control group. A significantly"/>
 <result pre="was only a borderline significant difference in risk of atopic" exact="dermatitis" post="between the EV cohort and control group. A significantly"/>
 <result pre="cohort and control group. A significantly increased cumulative risk of" exact="atopic dermatitis" post="in the follow-up period was observed. The difference between"/>
 <result pre="and control group. A significantly increased cumulative risk of atopic" exact="dermatitis" post="in the follow-up period was observed. The difference between"/>
 <result pre="the aforementioned study might be due to the definitions of" exact="disease" post="that were used. Enteroviruses have been investigated for several"/>
 <result pre="diversity between causative genotypes in each clinical presentation (15). Several" exact="chronic" post="diseases such as type I DM (46), leukemia (47),"/>
 <result pre="in each clinical presentation (15). Several chronic diseases such as" exact="type I" post="DM (46), leukemia (47), tic disorders (48), autoimmune disease"/>
 <result pre="(15). Several chronic diseases such as type I DM (46)," exact="leukemia" post="(47), tic disorders (48), autoimmune disease (49, 50), and"/>
 <result pre="as type I DM (46), leukemia (47), tic disorders (48)," exact="autoimmune" post="disease (49, 50), and cardiovascular diseases might be associated"/>
 <result pre="type I DM (46), leukemia (47), tic disorders (48), autoimmune" exact="disease" post="(49, 50), and cardiovascular diseases might be associated with"/>
 <result pre="leukemia (47), tic disorders (48), autoimmune disease (49, 50), and" exact="cardiovascular" post="diseases might be associated with enterovirus infections (9). While"/>
 <result pre="(49, 50), and cardiovascular diseases might be associated with enterovirus" exact="infections" post="(9). While some of these disorders and diseases have"/>
 <result pre="to have a strong causal relationship with enterovirus, such as" exact="type I" post="DM, others have shown conflicting findings in the literature."/>
 <result pre="available evidence indicates that enterovirus is closely linked with numerous" exact="chronic" post="health conditions, and that for children, this pathogen may"/>
 <result pre="epidemiological study demonstrating associations of common pediatric diseases with enterovirus" exact="infection" post="using data from a nationally representative cohort with a"/>
 <result pre="It does not contain data related to laboratory tests including" exact="viral" post="isolation from tissue, viral serum titer or reverse transcription"/>
 <result pre="data related to laboratory tests including viral isolation from tissue," exact="viral" post="serum titer or reverse transcription polymerase chain reaction (RT-PCR)."/>
 <result pre="relationship cannot be further explored in this study. In conclusion," exact="chronic" post="diseases, such as ADHD, epilepsy, and allergic diseases were"/>
 <result pre="and allergic diseases were found to be associated with enterovirus" exact="infection" post="during childhood. EV infection during early childhood might have"/>
 <result pre="found to be associated with enterovirus infection during childhood. EV" exact="infection" post="during early childhood might have long-term public health implications"/>
 <result pre="associated with enterovirus infection during childhood. EV infection during early" exact="childhood" post="might have long-term public health implications and thus prevention"/>
 <result pre="reviewed and approved by Institutional Review Board of Taichung Veterans" exact="General" post="Hospital. Written informed consent from the participants' legal guardian/next"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="of interest. Funding. This study is supported by Taichung Veterans" exact="General" post="Hospital Research Fund (Registration number TCVGH-NHRI10901, TCVGH-1097306C and TCVGH-1097328D)."/>
 <result pre="TCVGH-1097306C and TCVGH-1097328D). References References 1.PerrinJMAndersonLEvan CleaveJ. The rise in" exact="chronic" post="conditions among infants, children, and youth can be met"/>
 <result pre="children in US hospitals. Pediatrics. (2010) 126:638–46. 10.1542/peds.2009-165820855383 3.O'ConnorSMTaylorCEHughesJM. Emerging" exact="infectious" post="determinants of chronic diseases. Emerg Infect Dis. (2006) 12:1051–7."/>
 <result pre="hospitals. Pediatrics. (2010) 126:638–46. 10.1542/peds.2009-165820855383 3.O'ConnorSMTaylorCEHughesJM. Emerging infectious determinants of" exact="chronic" post="diseases. Emerg Infect Dis. (2006) 12:1051–7. 10.3201/eid1207.06003716836820 4.ZaoutisTKleinJD. Enterovirus"/>
 <result pre="10.1542/pir.19-6-1839613170 5.NoorAKrilovLR. Enterovirus infections. Pediatr Rev. (2016) 37:505–15. 10.1542/pir.2016-010327909105 6.LeeTCGuoHRSuHJYangYCChangHLChenKT." exact="Diseases" post="caused by enterovirus 71 infection. Pediatric infect Dis J."/>
 <result pre="(2016) 37:505–15. 10.1542/pir.2016-010327909105 6.LeeTCGuoHRSuHJYangYCChangHLChenKT. Diseases caused by enterovirus 71 infection." exact="Pediatric" post="infect Dis J. (2009) 28:904–10. 10.1097/INF.0b013e3181a41d6320118685 7.ChenKTChangHLWangSTChengYTYangJY. Epidemiologic features"/>
 <result pre="Dis J. (2009) 28:904–10. 10.1097/INF.0b013e3181a41d6320118685 7.ChenKTChangHLWangSTChengYTYangJY. Epidemiologic features of hand-foot-mouth" exact="disease" post="and herpangina caused by enterovirus 71 in Taiwan, 1998-2005."/>
 <result pre="(2009) 28:904–10. 10.1097/INF.0b013e3181a41d6320118685 7.ChenKTChangHLWangSTChengYTYangJY. Epidemiologic features of hand-foot-mouth disease and" exact="herpangina" post="caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics. (2007)"/>
 <result pre="1998-2005. Pediatrics. (2007) 120:e244–52. 10.1542/peds.2006-333117671037 8.ChangLYHsiaSHWuCTHuangYCLinKLFangTYet al.Outcome of enterovirus 71" exact="infections" post="with or without stage-based management: 1998 to 2002. Pediatric"/>
 <result pre="71 infections with or without stage-based management: 1998 to 2002." exact="Pediatric" post="Infect Dis J. (2004) 23:327–32. 10.1097/00006454-200404000-00010 9.TangJWHolmesCW. Acute and"/>
 <result pre="to 2002. Pediatric Infect Dis J. (2004) 23:327–32. 10.1097/00006454-200404000-00010 9.TangJWHolmesCW." exact="Acute" post="and chronic disease caused by enteroviruses. Virulence. (2017) 8:1062–5."/>
 <result pre="Pediatric Infect Dis J. (2004) 23:327–32. 10.1097/00006454-200404000-00010 9.TangJWHolmesCW. Acute and" exact="chronic" post="disease caused by enteroviruses. Virulence. (2017) 8:1062–5. 10.1080/21505594.2017.130862028362547 10.WijlaarsLPGilbertRHardelidP."/>
 <result pre="Infect Dis J. (2004) 23:327–32. 10.1097/00006454-200404000-00010 9.TangJWHolmesCW. Acute and chronic" exact="disease" post="caused by enteroviruses. Virulence. (2017) 8:1062–5. 10.1080/21505594.2017.130862028362547 10.WijlaarsLPGilbertRHardelidP. Chronic"/>
 <result pre="chronic disease caused by enteroviruses. Virulence. (2017) 8:1062–5. 10.1080/21505594.2017.130862028362547 10.WijlaarsLPGilbertRHardelidP." exact="Chronic" post="conditions in children and young people: learning from administrative"/>
 <result pre="data. Arch Dis Child. (2016) 101:881–5. 10.1136/archdischild-2016-31071627246068 11.LiCYLinRSLinCH. Urbanization and" exact="childhood" post="leukaemia in Taiwan. Int J Epidemiol. (1998) 27:587–91. 10.1093/ije/27.4.5879758111"/>
 <result pre="Arch Dis Child. (2016) 101:881–5. 10.1136/archdischild-2016-31071627246068 11.LiCYLinRSLinCH. Urbanization and childhood" exact="leukaemia" post="in Taiwan. Int J Epidemiol. (1998) 27:587–91. 10.1093/ije/27.4.5879758111 12.HoMChenERHsuKHTwuSJChenKTTsaiSFet"/>
 <result pre="(1998) 27:587–91. 10.1093/ije/27.4.5879758111 12.HoMChenERHsuKHTwuSJChenKTTsaiSFet al.. An epidemic of enterovirus 71" exact="infection" post="in Taiwan. Taiwan enterovirus epidemic working group. New Engl"/>
 <result pre="341:929–35. 10.1056/NEJM19990923341130110498487 13.ChangLYLinTYHsuKHHuangYCLinKLHsuehCet al.. Clinical features and risk factors of" exact="pulmonary oedema" post="after enterovirus-71-related hand, foot, and mouth disease. Lancet. (1999)"/>
 <result pre="Clinical features and risk factors of pulmonary oedema after enterovirus-71-related" exact="hand, foot, and mouth disease." post="Lancet. (1999) 354:1682–6. 10.1016/S0140-6736(99)04434-710568570 14.LinTYChangLYHsiaSHHuangYCChiuCHHsuehCet al.. The 1998 enterovirus"/>
 <result pre="management. Clin Infect Dis. (2002) 34(Suppl.2):S52–7. 10.1086/33881911938497 15.de GraafHPelosiECooperAPappachanJSykesKMacIntoshIet al.." exact="Severe" post="enterovirus infections in hospitalized children in the South of"/>
 <result pre="Infect Dis. (2002) 34(Suppl.2):S52–7. 10.1086/33881911938497 15.de GraafHPelosiECooperAPappachanJSykesKMacIntoshIet al.. Severe enterovirus" exact="infections" post="in hospitalized children in the South of England: clinical"/>
 <result pre="in the South of England: clinical phenotypes and causative genotypes." exact="Pediatric" post="Infect Dis J. (2016) 35:723–7. 10.1097/INF.000000000000109326882165 16.LeeHFChiCS. Enterovirus 71"/>
 <result pre="Infect Dis J. (2016) 35:723–7. 10.1097/INF.000000000000109326882165 16.LeeHFChiCS. Enterovirus 71 infection-associated" exact="acute" post="flaccid paralysis: a case series of long-term neurologic follow-up."/>
 <result pre="Clinical features and factors of unfavorable outcomes for non-polio enterovirus" exact="infection of the central nervous system" post="in northern Taiwan, 1994-2003. J Microbiol Immunol Infect. (2005)"/>
 <result pre="factors of unfavorable outcomes for non-polio enterovirus infection of the" exact="central nervous system" post="in northern Taiwan, 1994-2003. J Microbiol Immunol Infect. (2005)"/>
 <result pre="Taiwan, 1994-2003. J Microbiol Immunol Infect. (2005) 38:417–24.16341342 18.DalmanCAllebeckPGunnellDHarrisonGKristenssonKLewisGet al.." exact="Infections" post="in the CNS during childhood and the risk of"/>
 <result pre="Infect. (2005) 38:417–24.16341342 18.DalmanCAllebeckPGunnellDHarrisonGKristenssonKLewisGet al.. Infections in the CNS during" exact="childhood" post="and the risk of subsequent psychotic illness: a cohort"/>
 <result pre="psychotic illness: a cohort study of more than one million" exact="Swedish" post="subjects. Am J Psychiatry. (2008) 165:59–65. 10.1176/appi.ajp.2007.0705074018056223 19.MichaeliOKassisIShachor-MeyouhasYShaharERavidS. Long-term"/>
 <result pre="(2008) 165:59–65. 10.1176/appi.ajp.2007.0705074018056223 19.MichaeliOKassisIShachor-MeyouhasYShaharERavidS. Long-term motor and cognitive outcome of" exact="acute" post="encephalitis. Pediatrics. (2014) 133:e546–52. 10.1542/peds.2013-301024534397 20.TheodoreWH. Epilepsy and viral"/>
 <result pre="cognitive outcome of acute encephalitis. Pediatrics. (2014) 133:e546–52. 10.1542/peds.2013-301024534397 20.TheodoreWH." exact="Epilepsy" post="and viral infections. Epilepsy Curr. (2014) 14:35–42. 10.5698/1535-7511-14.s2.3524955074 21.MichosAGSyriopoulouVPHadjichristodoulouCDaikosGLLagonaEDouridasPet"/>
 <result pre="of acute encephalitis. Pediatrics. (2014) 133:e546–52. 10.1542/peds.2013-301024534397 20.TheodoreWH. Epilepsy and" exact="viral" post="infections. Epilepsy Curr. (2014) 14:35–42. 10.5698/1535-7511-14.s2.3524955074 21.MichosAGSyriopoulouVPHadjichristodoulouCDaikosGLLagonaEDouridasPet al.. Aseptic"/>
 <result pre="encephalitis. Pediatrics. (2014) 133:e546–52. 10.1542/peds.2013-301024534397 20.TheodoreWH. Epilepsy and viral infections." exact="Epilepsy" post="Curr. (2014) 14:35–42. 10.5698/1535-7511-14.s2.3524955074 21.MichosAGSyriopoulouVPHadjichristodoulouCDaikosGLLagonaEDouridasPet al.. Aseptic meningitis in"/>
 <result pre="and viral infections. Epilepsy Curr. (2014) 14:35–42. 10.5698/1535-7511-14.s2.3524955074 21.MichosAGSyriopoulouVPHadjichristodoulouCDaikosGLLagonaEDouridasPet al.." exact="Aseptic meningitis" post="in children: analysis of 506 cases. PLoS ONE. (2007)"/>
 <result pre="viral infections. Epilepsy Curr. (2014) 14:35–42. 10.5698/1535-7511-14.s2.3524955074 21.MichosAGSyriopoulouVPHadjichristodoulouCDaikosGLLagonaEDouridasPet al.. Aseptic" exact="meningitis" post="in children: analysis of 506 cases. PLoS ONE. (2007)"/>
 <result pre="506 cases. PLoS ONE. (2007) 2:e674. 10.1371/journal.pone.000067417668054 22.FowlkesALHonarmandSGlaserCYagiSSchnurrDObersteMSet al.. Enterovirus-associated" exact="encephalitis" post="in the California encephalitis project, 1998-2005. J Infect Dis."/>
 <result pre="ONE. (2007) 2:e674. 10.1371/journal.pone.000067417668054 22.FowlkesALHonarmandSGlaserCYagiSSchnurrDObersteMSet al.. Enterovirus-associated encephalitis in the" exact="California encephalitis" post="project, 1998-2005. J Infect Dis. (2008) 198:1685–91. 10.1086/59298818959496 23.ChangLYHuangLMGauSSWuYYHsiaSHFanTYet"/>
 <result pre="(2007) 2:e674. 10.1371/journal.pone.000067417668054 22.FowlkesALHonarmandSGlaserCYagiSSchnurrDObersteMSet al.. Enterovirus-associated encephalitis in the California" exact="encephalitis" post="project, 1998-2005. J Infect Dis. (2008) 198:1685–91. 10.1086/59298818959496 23.ChangLYHuangLMGauSSWuYYHsiaSHFanTYet"/>
 <result pre="356:1226–34. 10.1056/NEJMoa06595417377160 24.GauSSChangLYHuangLMFanTYWuYYLinTY. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71" exact="infection of the central nervous system." post="Pediatrics. (2008) 122:e452–8. 10.1542/peds.2007-379918606624 25.ChouICLinCCKaoCH. Enterovirus encephalitis increases the"/>
 <result pre="Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the" exact="central nervous system." post="Pediatrics. (2008) 122:e452–8. 10.1542/peds.2007-379918606624 25.ChouICLinCCKaoCH. Enterovirus encephalitis increases the"/>
 <result pre="the central nervous system. Pediatrics. (2008) 122:e452–8. 10.1542/peds.2007-379918606624 25.ChouICLinCCKaoCH. Enterovirus" exact="encephalitis" post="increases the risk of attention deficit hyperactivity disorder: a"/>
 <result pre="der WekkeJMeulmeesterJFRadderJJVerloove-VanhorickSP. School absence and treatment in school children with" exact="respiratory" post="symptoms in the Netherlands: data from the child health"/>
 <result pre="illnesses. Pediatr Allergy Immunol. (1994) 5:7–12. 10.1111/j.1399-3038.1994.tb00341.x7728232 31.MaziakWBehrensTBraskyTMDuhmeHRzehakPWeilandSKet al.. Are" exact="asthma" post="and allergies in children and adolescents increasing? Results from"/>
 <result pre="Allergy Immunol. (1994) 5:7–12. 10.1111/j.1399-3038.1994.tb00341.x7728232 31.MaziakWBehrensTBraskyTMDuhmeHRzehakPWeilandSKet al.. Are asthma and" exact="allergies" post="in children and adolescents increasing? Results from ISAAC phase"/>
 <result pre="surveys in Munster, Germany. Allergy. (2003) 58:572–9. 10.1034/j.1398-9995.2003.00161.x12823113 32.WoonPYChangWCLiangCCHsuCHKlahanSHuangYHet al.." exact="Increased" post="risk of atopic dermatitis in preschool children with kawasaki"/>
 <result pre="Germany. Allergy. (2003) 58:572–9. 10.1034/j.1398-9995.2003.00161.x12823113 32.WoonPYChangWCLiangCCHsuCHKlahanSHuangYHet al.. Increased risk of" exact="atopic dermatitis" post="in preschool children with kawasaki disease: a population-based study"/>
 <result pre="Allergy. (2003) 58:572–9. 10.1034/j.1398-9995.2003.00161.x12823113 32.WoonPYChangWCLiangCCHsuCHKlahanSHuangYHet al.. Increased risk of atopic" exact="dermatitis" post="in preschool children with kawasaki disease: a population-based study"/>
 <result pre="33.TagiyevaNSheikhA. Domestic exposure to volatile organic compounds in relation to" exact="asthma" post="and allergy in children and adults. Expert Rev Clin"/>
 <result pre="exposure to volatile organic compounds in relation to asthma and" exact="allergy" post="in children and adults. Expert Rev Clin Immunol. (2014)"/>
 <result pre="Child. (2006) 91:334–9. 10.1136/adc.2005.08039016428358 35.TurunenRKoistinenAVuorinenTArkuBSöderlund-VenermoMRuuskanenOet al.. The first wheezing episode:" exact="respiratory" post="virus etiology, atopic characteristics, and illness severity. Pediatr Allergy"/>
 <result pre="and illness severity. Pediatr Allergy Immunol. (2014) 25:796–803. 10.1111/pai.1231825444257 36.KumarRKFosterPSRosenbergHF." exact="Respiratory" post="viral infection, epithelial cytokines, and innate lymphoid cells in"/>
 <result pre="illness severity. Pediatr Allergy Immunol. (2014) 25:796–803. 10.1111/pai.1231825444257 36.KumarRKFosterPSRosenbergHF. Respiratory" exact="viral infection," post="epithelial cytokines, and innate lymphoid cells in asthma exacerbations."/>
 <result pre="Pediatr Allergy Immunol. (2014) 25:796–803. 10.1111/pai.1231825444257 36.KumarRKFosterPSRosenbergHF. Respiratory viral infection," exact="epithelial" post="cytokines, and innate lymphoid cells in asthma exacerbations. J"/>
 <result pre="Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in" exact="asthma" post="exacerbations. J Leukocyte Biol. (2014) 96:391–6. 10.1189/jlb.3RI0314-129R24904000 37.AjamianFWuYEbelingCIlarrazaROdemuyiwaSOMoqbelRet al.."/>
 <result pre="epithelial cytokines, and innate lymphoid cells in asthma exacerbations. J" exact="Leukocyte" post="Biol. (2014) 96:391–6. 10.1189/jlb.3RI0314-129R24904000 37.AjamianFWuYEbelingCIlarrazaROdemuyiwaSOMoqbelRet al.. Respiratory syncytial virus"/>
 <result pre="asthma exacerbations. J Leukocyte Biol. (2014) 96:391–6. 10.1189/jlb.3RI0314-129R24904000 37.AjamianFWuYEbelingCIlarrazaROdemuyiwaSOMoqbelRet al.." exact="Respiratory" post="syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel"/>
 <result pre="2,3-dioxygenase activity: a potential novel role in the development of" exact="allergic disease." post="Clin Exp Allergy. (2015) 45:644–59. 10.1111/cea.1249825627660 38.FeldmanASHeYMooreMLHershensonMBHartertTV. Toward primary"/>
 <result pre="allergic disease. Clin Exp Allergy. (2015) 45:644–59. 10.1111/cea.1249825627660 38.FeldmanASHeYMooreMLHershensonMBHartertTV. Toward" exact="primary" post="prevention of asthma. Reviewing the evidence for early-life respiratory"/>
 <result pre="Toward primary prevention of asthma. Reviewing the evidence for early-life" exact="respiratory" post="viral infections as modifiable risk factors to prevent childhood"/>
 <result pre="primary prevention of asthma. Reviewing the evidence for early-life respiratory" exact="viral" post="infections as modifiable risk factors to prevent childhood asthma."/>
 <result pre="prevention of asthma. Reviewing the evidence for early-life respiratory viral" exact="infections" post="as modifiable risk factors to prevent childhood asthma. Am"/>
 <result pre="early-life respiratory viral infections as modifiable risk factors to prevent" exact="childhood" post="asthma. Am J Respir Crit Care Med. (2015) 191:34–44."/>
 <result pre="Crit Care Med. (2015) 191:34–44. 10.1164/rccm.201405-0901PP25369458 39.TsukagoshiHIshiokaTNodaMKozawaKKimuraH. Molecular epidemiology of" exact="respiratory" post="viruses in virus-induced asthma. Front Microbiol. (2013) 4:278. 10.3389/fmicb.2013.0027824062735"/>
 <result pre="virus-induced asthma. Front Microbiol. (2013) 4:278. 10.3389/fmicb.2013.0027824062735 40.LeeZMHuangYHHoSCKuoHC. Correlation of" exact="symptomatic" post="enterovirus infection and later risk of allergic diseases via"/>
 <result pre="Front Microbiol. (2013) 4:278. 10.3389/fmicb.2013.0027824062735 40.LeeZMHuangYHHoSCKuoHC. Correlation of symptomatic enterovirus" exact="infection" post="and later risk of allergic diseases via a population-based"/>
 <result pre="cohort study. Medicine. (2017) 96:e5827. 10.1097/MD.000000000000582728121929 41.YehJJLinCLHsuWH. Effect of enterovirus" exact="infections" post="on asthma in young children: A national cohort study."/>
 <result pre="Medicine. (2017) 96:e5827. 10.1097/MD.000000000000582728121929 41.YehJJLinCLHsuWH. Effect of enterovirus infections on" exact="asthma" post="in young children: A national cohort study. Eur J"/>
 <result pre="systematic review. Lancet Infect Dis. (2016) 16:e64–75. 10.1016/S1473-3099(15)00543-526929196 43.Smith-NorowitzTACarvajal-RagaSWeedonJJoksRNorowitzKBWeaverDet al.." exact="Increased" post="seroprevalence of Enterovirus 71 IgE antibodies in asthmatic compared"/>
 <result pre="Lower anti-echovirus antibody responses in children presenting to hospital with" exact="asthma" post="exacerbations. Clin Exp Allergy. (2015) 45:1523–30. 10.1111/cea.1250125640320 45.WuJCuiDYangXLouJLinJYeXet al.."/>
 <result pre="asthma exacerbations. Clin Exp Allergy. (2015) 45:1523–30. 10.1111/cea.1250125640320 45.WuJCuiDYangXLouJLinJYeXet al.." exact="Increased" post="frequency of circulating follicular helper T cells in children"/>
 <result pre="Increased frequency of circulating follicular helper T cells in children" exact="with hand," post="foot, and mouth disease caused by enterovirus 71 infection."/>
 <result pre="frequency of circulating follicular helper T cells in children with" exact="hand, foot, and mouth disease" post="caused by enterovirus 71 infection. J Immunol Res. (2014)"/>
 <result pre="helper T cells in children with hand, foot, and mouth" exact="disease" post="caused by enterovirus 71 infection. J Immunol Res. (2014)"/>
 <result pre="infection. J Immunol Res. (2014) 2014:651872. 10.1155/2014/65187225013818 46.LinHCWangCHTsaiFJHwangKPChenWLinCCet al.. Enterovirus" exact="infection" post="is associated with an increased risk of childhood type"/>
 <result pre="al.. Enterovirus infection is associated with an increased risk of" exact="childhood" post="type 1 diabetes in Taiwan: a nationwide population-based cohort"/>
 <result pre="Enterovirus infection is associated with an increased risk of childhood" exact="type 1" post="diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia."/>
 <result pre="is associated with an increased risk of childhood type 1" exact="diabetes" post="in Taiwan: a nationwide population-based cohort study. Diabetologia. (2015)"/>
 <result pre="cohort study. Diabetologia. (2015) 58:79–86. 10.1007/s00125-014-3400-z25335440 47.LinJNLinCLLinMCLaiCHLinHHYangCHet al.. Risk of" exact="leukaemia" post="in children infected with enterovirus: a nationwide, retrospective, population-based,"/>
 <result pre="49.ChristensenMLPachmanLMSchneidermanRPatelDCFriedmanJM. Prevalence of Coxsackie B virus antibodies in patients with" exact="juvenile" post="dermatomyositis. Arthritis Rheum. (1986) 29:1365–70. 10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for"/>
 <result pre="of Coxsackie B virus antibodies in patients with juvenile dermatomyositis." exact="Arthritis" post="Rheum. (1986) 29:1365–70. 10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for coxsackievirus infection"/>
 <result pre="dermatomyositis. Arthritis Rheum. (1986) 29:1365–70. 10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for coxsackievirus" exact="infection" post="in primary Sjogren's syndrome. Arthritis Rheum. (2004) 50:2897–902. 10.1002/art.2046315457458"/>
 <result pre="Rheum. (1986) 29:1365–70. 10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for coxsackievirus infection in" exact="primary" post="Sjogren's syndrome. Arthritis Rheum. (2004) 50:2897–902. 10.1002/art.2046315457458"/>
 <result pre="(1986) 29:1365–70. 10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for coxsackievirus infection in primary" exact="Sjogren's syndrome." post="Arthritis Rheum. (2004) 50:2897–902. 10.1002/art.2046315457458"/>
 <result pre="10.1002/art.17802911093022759 50.TriantafyllopoulouATapinosNMoutsopoulosHM. Evidence for coxsackievirus infection in primary Sjogren's syndrome." exact="Arthritis" post="Rheum. (2004) 50:2897–902. 10.1002/art.2046315457458"/>
</results>
